Professor of Genetics at the Federal University of Rio Grande do Sul
Study Location Principal Investigator, Porto Alegre, Brazil, of the Zika Genetics ConsortiumMember of the Steering Group for Microcephaly Epidemics, Brazil Ministry of Health President of the Brazilian Society of Medical GeneticsHead of Medical Genetics Service, Hospital de Clinicals de Porto Alegre Dr. Schuler-Faccini is a physician-scientist who has made fundamental contributions to the study of human development, having identified misoprostol as a human teratogen and identified the mechanism of thalidomide teratogenesis. She has been a leader in describing and characterizing the Zika virus pandemic from the very beginning, publishing a 2015 report that first suggested an association with microcephaly in MMWR. Dr. Schuler-Faccini contributes to the research study with recruitment and retention of study participants; supervision of collection, logging and shipments of samples; supervision of clinical data collection and managing and updating RedCap study information. Dr. Schuler-Faccini will also contribute to interpretation of whole genome sequencing results.